Edition:
United States

Neurosearch A/S (NEUR.CO)

NEUR.CO on Copenhagen Stock Exchange

87.00DKK
19 Jun 2019
Change (% chg)

kr.3.00 (+3.57%)
Prev Close
kr.84.00
Open
kr.82.50
Day's High
kr.87.00
Day's Low
kr.82.00
Volume
1,024
Avg. Vol
885
52-wk High
kr.96.00
52-wk Low
kr.62.00

Latest Key Developments (Source: Significant Developments)

Neurosearch FY Operating Loss Now Seen At DKK 9-13 Million
Monday, 17 Jun 2019 02:00am EDT 

June 17 (Reuters) - Neurosearch A/S ::ANNOUNCES CHANGE TO ITS FINANCIAL OUTLOOK FOR 2019.OPERATING LOSS IS NOW EXPECTED TO BE IN REGION OF DKK 9-13 MILLION.IN ANNUAL REPORT 2018, CO ANNOUNCED EXPECTED OPERATING LOSS (ON A GOING-CONCERN ASSUMPTION) OF ABOUT DKK 4-6 MLN.PREVIOUS OUTLOOK DID NOT INCLUDE EXPENSES RELATED TO PREPARATIONS FOR POTENTIAL MERGER OR LIKE WITH NTG HOLDING.  Full Article

Neurosearch Signs LoI With NTG
Friday, 5 Apr 2019 01:18pm EDT 

April 8 (Reuters) - Neurosearch A/S ::SAID ON FRIDAY SIGNING OF LETTER OF INTENT WITH NTG AND REASON FOR PROPOSALS TO THE GENERAL MEETING.NEUROSEARCH AND NTG HAVE SIGNED A NON-BINDING LETTER OF INTENT IN RESPECT OF DEAL.NTG ACCEPTED OBLIGATION TO COVER 50 PERCENT OF CO'S COSTS FOR EXTERNAL ADVISERS IF DEAL IS NOT COMPLETED ON OR BEFORE 31 DECEMBER 2019.NTG HOLDING IS THE COMPANY’S BIGGEST SHAREHOLDER, HOLDING 22.95 PCT OF THE SHARE CAPITAL.  Full Article

Neurosearch FY Operating Loss Widens To DKK 2.4 Million
Monday, 25 Feb 2019 02:00am EST 

Feb 25 (Reuters) - Neurosearch A/S ::REG-NEUROSEARCH A/S RELEASING ANNUAL REPORT 2018.FY OPERATING LOSS DKK 2.4 MILLION VERSUS LOSS DKK 1.0 MILLION YEAR AGO.FOR 2019, NEUROSEARCH EXPECTS AN OPERATING LOSS OF DKK 4-6 MILLION.  Full Article

Amici Capital Disposes Remaining Shares In Neurosearch
Friday, 14 Sep 2018 08:55am EDT 

Sept 14 (Reuters) - Neurosearch A/S ::REG-MAJOR SHAREHOLDER ANNOUNCEMENT.AMICI CAPITAL, LLC HAS DISPOSED OF ITS REMAINING SHARES IN NEUROSEARCH.LATEST AMICI CAPITAL, LLC HOLDING IN NEUROSEARCH WAS 4.07 PERCENT OF SHARES AND VOTING RIGHTS.  Full Article

Neurosearch H1 Operating Loss Dkk 2.8 Million
Thursday, 30 Aug 2018 02:00am EDT 

Aug 30 (Reuters) - Neurosearch A/S ::REG-NEUROSEARCH A/S – H1 REPORT 2018.H1 OPERATING LOSS DKK 2.8 MILLION VERSUS LOSS DKK 2.3 MILLION YEAR AGO.2018 OPERATING LOSS IS ESTIMATED TO BE APPROXIMATELY DKK 5 MILLION WITHOUT COMPLETION OF AGREEMENT WITH TEVA.  Full Article

Neurosearch: Glaxo Group Limited Disposes All Its Shares In Neurosearch
Thursday, 23 Aug 2018 02:05am EDT 

Aug 23 (Reuters) - Neurosearch A/S ::REG-MAJOR SHAREHOLDING ANNOUNCEMENT.GLAXO GROUP LIMITED DISPOSED OF ALL OF ITS SHARES IN NEUROSEARCH.  Full Article

NeuroSearch: Gefion Group Investments A/S Provisionally Extends Offer Period
Monday, 25 Jun 2018 10:25am EDT 

June 25 (Reuters) - Neurosearch A/S ::REG-GEFION GROUP INVESTMENTS A/S PROVISIONALLY EXTENDS OFFER PERIOD.BOARD RECOMMENDS NEUROSEARCH'S SHAREHOLDERS TO AWAIT BOARD'S STATEMENT PRIOR TO POTENTIALLY ACCEPTING OFFER..GEFION GROUP INVESTMENTS A/S TODAY INFORMED NEUROSEARCH THAT IT HAS DECIDED TO INCREASE ITS OFFER TO DKK 4.50 PER SHARE.  Full Article

RegNeurosearch And Teva Pharmaceutical International Enter Into Agreement On Outstanding Obligations
Wednesday, 16 May 2018 01:22pm EDT 

May 16 (Reuters) - Neurosearch A/S ::REG-NEUROSEARCH AND TEVA PHARMACEUTICAL INTERNATIONAL ENTER INTO AGREEMENT ON OUTSTANDING OBLIGATIONS.AGREEMENT TO RELEASE TEVA FROM OUTSTANDING OBLIGATIONS PURSUANT TO 2012 AGREEMENT CONCERNING TRANSFER OF CO'S RIGHTS IN AND TO PRIDOPIDINE.PROVIDED AGREEMENT IS COMPLETED,CO'S FINANCIAL EXPECTATIONS FOR 2018 WILL BE AMENDED FROM LOSS OF DKK 3.5-4.5 MILLION TO LOSS OF DKK 0.8-1.8 MILLION.  Full Article

Neurosearch: Gefion To Launch A Takeover Offer On Neurosearch
Friday, 27 Apr 2018 03:55am EDT 

April 27 (Reuters) - Neurosearch A/S ::REG-DECISION ON LAUNCH OF CONDITIONAL, VOLUNTARY OFFER.RECEIVED A NOTICE FROM GEFION GROUP INVESTMENTS A/S THAT GEFION DECIDED TO LAUNCH A CONDITIONAL, VOLUNTARY TAKEOVER OFFER.NEUROSEARCH - GEFION OFFER TO ACQUIRE ENTIRE SHARE CAPITAL OF NEUROSEARCH (EXCLUDING ANY TREASURY SHARES) AGAINST CASH CONSIDERATION OF DKK 4.00 PER SHARE.BOARD WITHDRAWS PROPOSAL FOR ANNUAL GENERAL MEETING TO DECIDE TO LIQUIDATE NEUROSEARCH.RECOMMENDS SHAREHOLDERS TO VOTE AGAINST CONVERSION OF COMPANY INTO AN INVESTMENT COMPANY..BOARD RECOMMENDS NEUROSEARCH'S SHAREHOLDERS TO AWAIT THIS STATEMENT PRIOR TO POTENTIALLY ACCEPTING OFFER.  Full Article

Neurosearch Says Is Investigating Potential Sale Of Company
Thursday, 19 Apr 2018 09:52am EDT 

April 19 (Reuters) - NEUROSEARCH A/S ::SAYS IS IN DISCUSSIONS WITH REGARD TO POTENTIAL SALE OF ITS RIGHTS TO PRIDOPIDINE FOR A SMALL SEVEN FIGURE AMOUNT IN DKK.SAYS IS STILL INVESTIGATING POTENTIAL SALE OF COMPANY.  Full Article

No consensus analysis data available.